The role of PET imaging in lymphoma

被引：64
作者：
Burton, C
Ell, P
Linch, D
机构：
[1] UCL, Dept Haematol, London WC1E 8HX, England
[2] Middlesex Hosp, Dept Nucl Med, London, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2004年 / 126卷 / 06期
关键词：
2-fluoro-2-deoxy-D-glucose-positron emission tomography; positron emission tomography; lymphoma; non-Hodgkin's lymphoma; hodgkin lymphoma/disease;
D O I：
10.1111/j.1365-2141.2004.05069.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Positron emission tomography using fluorine-18 (FDG-PET) is increasingly used in the staging and follow-up of malignant lymphomas, although its precise role has not yet been determined. This review considers the results reported at-the different stages in the disease history and separately considers the major histological subtypes. Attention is given to the situations in which PET scanning is most likely to influence management. Finally, this review discusses ongoing developments in PET scanning with improved resolution and different radiolabelled tracers.
引用
收藏
页码：772 / 784
页数：13
相关论文
共 84 条
[1]   Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology [J].
Antoch, G ;
Vogt, FM ;
Freudenberg, LS ;
Nazaradeh, F ;
Goehde, SC ;
Barkhausen, J ;
Dahmen, G ;
Bockisch, A ;
Debatin, JF ;
Ruehm, SG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (24) :3199-3206
[2]   Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDC-PET) for accurate staging of Hodgkin's disease [J].
Bangerter, M ;
Moog, F ;
Buchmann, I ;
Kotzerke, J ;
Griesshammer, M ;
Hafner, M ;
Elsner, K ;
Frickhofen, N ;
Reske, SN ;
Bergmann, L .
ANNALS OF ONCOLOGY, 1998, 9 (10) :1117-1122
[3]  
Bangerter M, 1999, ACTA ONCOL, V38, P799
[4]  
Barthel H, 2003, CANCER RES, V63, P3791
[5]   Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation [J].
Becherer, A ;
Mitterbauer, M ;
Jaeger, U ;
Kalhs, P ;
Greinix, HT ;
Karanikas, G ;
Pötzi, C ;
Raderer, M ;
Dudczak, R ;
Kletter, K .
LEUKEMIA, 2002, 16 (02) :260-267
[6]   Utility of gallium-67 scintigraphy in low-grade non-Hodgkin's lymphoma [J].
BenHaim, S ;
BarShalom, R ;
Israel, O ;
Haim, N ;
Epelbaum, R ;
BenSchachar, M ;
Gaitini, D ;
Kolodny, GM ;
Front, D .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (06) :1936-1942
[7]  
Buchmann I, 2001, CANCER, V91, P889
[8]   RESIDUAL MASS IN LYMPHOMA MAY NOT BE RESIDUAL DISEASE [J].
CANELLOS, GP .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (06) :931-933
[9]   Detection of lymphoma in bone marrow by whole-body positron emission tomography [J].
Carr, R ;
Barrington, SF ;
Madan, B ;
O'Doherty, MJ ;
Saunders, CAB ;
van der Walt, J ;
Timothy, AR .
BLOOD, 1998, 91 (09) :3340-3346
[10]   Image analysis in patients with cancer studied with a combined PET and CT scanner [J].
Charron, M ;
Beyer, T ;
Bohnen, NN ;
Kinahan, PE ;
Dachille, M ;
Jerin, J ;
Nutt, R ;
Meltzer, CC ;
Villemagne, V ;
Townsend, DW .
CLINICAL NUCLEAR MEDICINE, 2000, 25 (11) :905-910
123456789